Tenet Healthcare Corp: Form 10-Q for the period ended Jun 30, 2018
Filed with the SEC on Aug 6, 2018 and accepted by EDGAR at Aug 6, 2018, 16:23 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2018-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2018-04-01 to 2018-06-30 | $4.51bn | us-gaap:Revenues |
| Revenue | 6 months2018-01-01 to 2018-06-30 | $9.21bn | us-gaap:Revenues |
| Operating income | 3 months2018-04-01 to 2018-06-30 | $406.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2018-01-01 to 2018-06-30 | $923.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2018-04-01 to 2018-06-30 | $254.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2018-01-01 to 2018-06-30 | $509.0m | us-gaap:InterestExpense |
| Income tax | 3 months2018-04-01 to 2018-06-30 | $44.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2018-01-01 to 2018-06-30 | $114.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2018-04-01 to 2018-06-30 | $108.0m | us-gaap:ProfitLoss |
| Net income | 6 months2018-01-01 to 2018-06-30 | $299.0m | us-gaap:ProfitLoss |
| Diluted EPS | 3 months2018-04-01 to 2018-06-30 | $0.25 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2018-01-01 to 2018-06-30 | $1.21 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2018-04-01 to 2018-06-30 | $0.25 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2018-01-01 to 2018-06-30 | $1.23 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2018-04-01 to 2018-06-30 | 104,177,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2018-01-01 to 2018-06-30 | 103,416,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2018-01-01 to 2018-06-30 | $461.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2018-01-01 to 2018-06-30 | $268.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2018-06-30 | $403.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2018-06-30 | $4.71bn | us-gaap:AssetsCurrent |
| Total assets | At period end2018-06-30 | $22.34bn | us-gaap:Assets |
| Current liabilities | At period end2018-06-30 | $4.35bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2018-06-30 | $20.34bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2018-06-30 | −$154.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000070318-18-000030. Last ingested by Listed: Nov 15, 2026, 02:42 ET. Listed shows no prices and gives no investment advice.